Koers Dawnrays Pharmaceutical (Holdings) Limited
Aandelen
2348
KYG2687M1006
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,17 HKD | 0,00% | +1,74% | +11,43% |
Omzet 2022 | 1,28 mld. 176 mln. 1,38 mld. 165 mln. | Omzet 2023 | 1,15 mld. 159 mln. 1,24 mld. 149 mln. | Marktkapitalisatie | 1,43 mld. 198 mln. 1,55 mld. 185 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 358 mln. 49,41 mln. 387 mln. 46,21 mln. | Nettowinst (verlies) 2023 | 326 mln. 44,99 mln. 352 mln. 42,08 mln. | EV/omzet 2022 | 0,54 x |
Nettoliquiditeiten 2022 | 1,07 mld. 148 mln. 1,16 mld. 139 mln. | Nettoliquiditeiten 2023 | 1,05 mld. 145 mln. 1,14 mld. 136 mln. | EV/omzet 2023 | 0,33 x |
K/w-verhouding 2022 |
4,93
x | K/w-verhouding 2023 |
4,4
x | Werknemers | 1.143 |
Dividendrendement 2022 |
6,63% | Dividendrendement 2023 |
7,61% | Vrij verhandelbaar | 39,97% |
1 week | +1,74% | ||
1 maand | -2,50% | ||
3 maanden | +7,34% | ||
6 maanden | +8,33% | ||
Lopend jaar | +11,43% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wei Xian Wu
CEO | Chief Executive Officer | 55 | 16-02-22 |
Yi jun Wu
DFI | Director of Finance/CFO | 59 | 01-12-02 |
Kei Ling Li
CHM | Chairman | 75 | 01-10-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kei Ling Li
CHM | Chairman | 75 | 01-10-02 |
Yung Lai Hung
BRD | Director/Board Member | 79 | 01-10-02 |
Hong Man Leung
BRD | Director/Board Member | 49 | 01-11-05 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,17 | 0,00% | 40 000 |
25-04-24 | 1,17 | 0,00% | 0 |
24-04-24 | 1,17 | -1,68% | 144 000 |
23-04-24 | 1,19 | +2,59% | 112 000 |
22-04-24 | 1,16 | +0,87% | 12 000 |
uitgestelde koers Hong Kong S.E., 26 april 2024 om 10:08 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+11,43% | 224 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |